Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameACS MULTI-LINK RX/OTW DUET CORONARY STENT SYSTEMS
Classification Namestent, coronary
Generic Namecoronary stent system
ApplicantGUIDANT CORP.
PMA NumberP970020
Supplement NumberS040
Date Received12/26/2001
Decision Date08/06/2002
Product Code
MAF[ Registered Establishments with MAF ]
Docket Number 04M-0024
Notice Date 01/21/2004
Advisory Committee Cardiovascular
Supplement Typepanel track
Supplement Reason labeling change - indications
Expedited Review Granted? No
Combination Product No
Information About: Labeling, Approval Order, Summary of Safety and Effectiveness
Approval Order Statement 
Approval for the addition of a new indication. The acs multi-link devices are indicated for the following (see individualization of treatment): 1) improving coronary luminal diameter in patients with symptomatic ischemic heart disease due to discrete de novo or restenotic native coronary artery lesions length <= 25 mm with a reference vessel diameter of 3. 0 mm to 4. 0 mm. 2) improving coronary luminal diameter in patients with symptomatic ischemic heart disease due to lesions in saphenous vein bypass grafts length <= 35 mm with a reference vessel diameter of 3. 0 mm to 4. 0 mm. 3) restoring coronary flow in patients experiencing acute myocardial infarction, as confirmed by st segment elevation or angiographic findings, who present within 12 hours of symptom onset with native coronary artery lesions of length <= 35 mm with a reference vessel diameter of 2. 5 mm to 4. 0 mm. 4) treatment of abrupt or threatened closure in patients with failed interventional therapy in lesions length <= 35 mm with a reference vessel diameter of 2. 5 mm to 4. 0 mm. Long-term outcome (beyond 6 months) for this permanent implant is unknown at present.
Approval Order Approval Order
-
-